VESIsorb® Evidence for Rapid and Maximum BCP Absorption

Clinical Evidence: VESIsorb® is a safe and effective drug delivery pharmaceutical technology that can help  dramatically improve the bioavailability of poorly absorbed ingredients such as THC, CBD and terpenes (BCP). A specific clinical trial (among many trials conducted for VESIsorb® products) tested for improvement in BCP absorption and showed a 3.6 x increase in absorption (Cmax) and 2x faster (Tmax) than comparable CBD products without VESIsorb®. 

Clinical and Scientific Evidence References: 

Modinger, Yvonne et al, Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS) Molecules 2022, 27(9), 2860;